Designating the month of September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania.
Summary
House Resolution 304 designates September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania. The resolution is largely commemorative and educational: it recites background information about prostate cancer, including its prevalence, risk factors, symptoms, screening methods, and the importance of consulting a physician about testing. It also cites national and state-level estimates about diagnoses and deaths in Pennsylvania to underscore the public health significance of the disease.
The resolution does not create a regulatory program, mandate insurance coverage, or change clinical practice requirements. Instead, it formally recognizes prostate cancer awareness for the month of September and is intended to encourage public education, screening awareness, and early detection among men, especially those at higher risk or with a family history of the disease.
Impact
HR304 has no direct effect on the Pennsylvania Consolidated Statutes or other substantive state law; it is a nonbinding House resolution. Its practical impact is symbolic and promotional, using official legislative recognition to support awareness campaigns, public health outreach, and discussion of prostate cancer screening and early diagnosis among affected populations and healthcare providers.
Sentiment
The available voting history suggests strong support for the resolution. The House Health Committee reported the bill as committed by a 25-1 vote, indicating broad bipartisan agreement that prostate cancer awareness is a worthwhile public health observance. No committee transcript is available, and the bill text itself is uncontroversial in tone, focusing on health education and disease awareness rather than policy change.
Contention
There is little visible contention around the resolution. The only recorded opposition is the single nay vote in committee, but no explanation is provided in the available materials. Because the measure is a ceremonial awareness resolution rather than a substantive health policy bill, any disagreement would likely be limited to the use of legislative time for commemorative resolutions rather than the merits of prostate cancer awareness itself.